Actively Recruiting
Anxiolytic Effect of Virtual Reality Immersion Versus Midazolam Premedication in Patients Undergoing Dacryocystorhinostomy Surgery
Led by Cairo University · Updated on 2025-07-03
40
Participants Needed
1
Research Sites
30 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim is to investigate the anxiolytic effect, and hemodynamic stability of using virtual reality immersion in adult patients undergoing Dacryocystorhinostomy (DCR) operation under general anesthesia and to compare its effect to that of using Midazolam as a premedication.
CONDITIONS
Official Title
Anxiolytic Effect of Virtual Reality Immersion Versus Midazolam Premedication in Patients Undergoing Dacryocystorhinostomy Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 18-65.
- Both sexes.
- American Society of Anesthesiologists (ASA) classification I - II.
- Patient undergoing Dacryocystorhinostomy Surgery (DCR) under general anesthesia.
You will not qualify if you...
- Patient refusal.
- Patients with cardiac diseases.
- Patients with renal diseases.
- Patients with drug sensitivity and seizures.
- Substance abuse and addiction.
- Claustrophobia.
- Patients with cerebrovascular disease.
- Psychiatric and cognitive disorder.
- Patients with severe teary eyes and blurring of vision.
- Patients who express discomfort during the test.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Cairo University
Cairo, Egypt, 12613
Actively Recruiting
Research Team
H
Hebatullah S Abdelhamid, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here